MCM7 as a Target in Lung Cancer
Author Information
Author(s): Toyokawa Gouji, Masuda Ken, Daigo Yataro, Cho Hyun-Soo, Yoshimatsu Masanori, Takawa Masashi, Hayami Shinya, Maejima Kazuhiro, Chino Makoto, Field Helen I, Neal David E, Tsuchiya Eiju, Ponder Bruce AJ, Maehara Yoshihiko, Nakamura Yusuke, Hamamoto Ryuji
Primary Institution: Institute of Medical Science, The University of Tokyo
Hypothesis
Is MCM7 a potential therapeutic target and prognostic marker in non-small cell lung cancer?
Conclusion
MCM7 is overexpressed in various cancers and is associated with poor prognosis in non-small cell lung cancer patients.
Supporting Evidence
- MCM7 was positively stained in 196 of 331 non-small cell lung cancer cases.
- Elevated MCM7 expression was associated with poor prognosis for NSCLC patients.
- Knockdown of MCM7 inhibited cancer cell growth more efficiently than in normal cells.
Takeaway
MCM7 is a protein that can help doctors understand how serious lung cancer is and could be a target for new cancer treatments.
Methodology
The study involved immunohistochemical analysis, qRT-PCR, and cell line experiments to evaluate MCM7 expression in cancer tissues and its effects on cell growth.
Limitations
MCM7 status did not show statistical significance as an independent prognostic factor in multivariate analysis.
Participant Demographics
Patients with non-small cell lung cancer who underwent surgical resection.
Statistical Information
P-Value
0.0055
Confidence Interval
1.134-2.110
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website